```html

Sexually Transmitted Infection (STI) – A Patient‑Friendly Medical Guide

Overview

Sexually transmitted infections (STIs), formerly called sexually transmitted diseases (STDs), are infections passed primarily through sexual contact—including vaginal, anal, or oral sex. Over 1 million new STIs are diagnosed in the United States each day, and the World Health Organization estimates >376 million new cases of the four most common curable STIs (chlamydia, gonorrhea, syphilis, and trichomoniasis) worldwide each year <sup>1</sup>. Anyone who is sexually active can acquire an STI, regardless of age, gender, sexual orientation, or relationship status.

STIs range from asymptomatic, easily cured infections (e.g., chlamydia) to chronic, potentially life‑threatening diseases (e.g., HIV, syphilis). Early detection, appropriate treatment, and preventive measures are essential to protect personal health and public safety.

Symptoms

Many STIs produce no noticeable signs, especially in the early stages. When symptoms do appear, they can vary by pathogen, sex of the infected partner, and anatomic site of infection. Below is a comprehensive list of common symptoms, grouped by system:

Genital Symptoms

• Discharge: Watery, yellow‑green, or frothy discharge from the penis or vagina.
• Genital sores or ulcers: Soft, painless chancres (syphilis) or painful vesicles (herpes).
• Itching or burning: Irritation of the vulva, foreskin, or perianal skin.
• Painful urination: Burning sensation during micturition, often seen with chlamydia, gonorrhea, or trichomoniasis.
• Pain during intercourse: Dyspareunia, especially in women with pelvic inflammatory disease (PID).

Anal Symptoms

• Rectal discharge, bleeding, or pain.
• Anal warts (HPV) or ulcerative lesions (herpes, syphilis).

Oral Symptoms

• Sores or blisters on the lips, tongue, or inside the mouth (herpes, syphilis).
• Persistent sore throat or swollen tonsils (rarely gonorrhea).

Systemic Symptoms

• Fever, chills, or night sweats (especially with HIV, syphilis, or hepatitis).
• Fatigue, malaise, or unexplained weight loss.
• Lymphadenopathy – swollen, tender lymph nodes in the groin, neck, or armpits.
• Joint pain or swelling (reactive arthritis linked to chlamydia).

Because up to 70 % of chlamydia and 50 % of gonorrhea infections are asymptomatic in women, routine screening is critical even when you feel well.

Causes and Risk Factors

STIs are caused by a variety of microorganisms:

• Bacteria: Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidum (syphilis), Mycoplasma genitalium.
• Viruses: Human papillomavirus (HPV), Herpes simplex virus (HSV‑1/2), Human immunodeficiency virus (HIV), Hepatitis B & C.
• Parasites: Trichomonas vaginalis, Pubic lice (Pthirus pubis), Scabies.

Key Risk Factors

• Unprotected sex: No condom or dental dam use.
• Multiple partners: Increases exposure opportunities.
• Sexual networks with high prevalence: Certain communities have higher baseline rates.
• History of prior STI: Indicates ongoing risky behavior.
• Substance use (alcohol, drugs): Can impair judgment and lead to unsafe practices.
• Pregnancy: Some STIs (e.g., syphilis, gonorrhea) are more easily transmitted to the fetus.
• Immunocompromise: HIV or immunosuppressive therapy can worsen infection courses.

Diagnosis

Testing strategies depend on the suspected pathogen, exposure history, and anatomic site. Prompt diagnosis reduces transmission and complications.

General Screening Recommendations

• Women ≤ 24 years and sexually active women > 24 years with risk factors: annual chlamydia & gonorrhea NAAT (nucleic acid amplification test) of urine or vaginal swab.
• All sexually active men who have sex with men (MSM): at least annual syphilis serology, HIV test, and extragenital (pharyngeal/rectal) NAAT for gonorrhea & chlamydia.
• Pregnant individuals: syphilis serology, HIV, hepatitis B surface antigen, and chlamydia/gonorrhea screening at first prenatal visit.

Specific Tests

• NAAT (PCR): Gold standard for chlamydia, gonorrhea, and Mycoplasma genitalium—high sensitivity (>95 %).
• Serologic tests: RPR/VDRL for syphilis, ELISA/Western blot for HIV, and antigen‑antibody combo for hepatitis B/C.
• Culture: For Neisseria gonorrhoeae when antimicrobial susceptibility is needed.
• Pap smear with HPV testing: Screening for cervical dysplasia and high‑risk HPV types.
• Visual inspection: Diagnosis of genital warts (HPV) or herpetic lesions; may be confirmed with PCR swab.

Always inform your provider of any recent antibiotic use, as it can affect test accuracy.

Treatment Options

Treatment varies by organism, resistance patterns, and patient factors (e.g., pregnancy). Below are first‑line regimens recommended by the CDC (2024) and WHO.

Bacterial STIs

• Chlamydia: Doxycycline 100 mg orally twice daily for 7 days (preferred) or azithromycin 1 g single dose (alternative).
• Gonorrhea: Ceftriaxone 500 mg IM single dose plus azithromycin 1 g PO single dose (dual therapy to cover possible co‑infection).
• Syphilis: Benzathine penicillin G 2.4 MU IM single dose for primary/secondary disease; weekly for three weeks for late latent.
• Trichomoniasis: Metronidazole 2 g PO single dose or 500 mg BID for 7 days.

Viral STIs

• HPV: No antiviral cure; management focuses on lesion removal (cryotherapy, topical imiquimod) and vaccination for prevention.
• Herpes simplex virus: Acyclovir 400 mg PO TID, valacyclovir 500 mg PO BID, or famciclovir 250 mg PO TID for 7‑10 days (episodes) plus suppressive therapy for frequent recurrences.
• HIV: Combination antiretroviral therapy (ART) tailored to resistance profile; lifelong adherence is essential.
• Hepatitis B: Tenofovir or entecavir for chronic infection; vaccine for prevention.

Lifestyle & Supportive Measures

• Abstain from sexual activity until treatment is completed and partners are cleared.
• Use condoms consistently and correctly during intercourse.
• Treat all sexual partners simultaneously to avoid reinfection.
• Consider vaccination (HPV, hepatitis B) where applicable.

Living with Sexually Transmitted Infection (STI)

Even after successful treatment, living with a history of STI can raise emotional, relational, and health‑maintenance questions. Below are practical tips to maintain wellbeing.

Follow‑up Care

• Repeat testing 3 months after treatment for chlamydia/gonorrhea and syphilis to confirm cure.
• Maintain regular HIV viral load and CD4 monitoring if HIV‑positive.
• Women treated for chlamydia or gonorrhea should be screened for PID symptoms (pelvic pain, abnormal bleeding).

Emotional Support

• Seek counseling or support groups—stigma can affect mental health.
• Inform trusted partners; honest communication reduces anxiety and promotes safer sex.
• Consider mental‑health screening for depression or anxiety, especially with chronic viral infections.

Healthy Lifestyle

• Balanced diet, regular exercise, and adequate sleep bolster the immune system.
• Avoid smoking and excessive alcohol, both of which can impair immune response and wound healing.
• Stay up to date with vaccinations (HPV, hepatitis A/B, flu).

Practical Day‑to‑Day Tips

• Carry condoms and use them for every sexual encounter.
• Schedule routine STI screenings at least annually, more often if you have multiple partners.
• Keep a personal health record of test dates and results for easy sharing with providers.
• Disclose any new symptoms promptly—even mild ones—to your clinician.

Prevention

Prevention is a combination of behavioral, biomedical, and community strategies.

Barrier Methods

• Male latex condoms are ~85 % effective when used correctly.
• Female condoms and dental dams add protection for oral sex.

Vaccination

• HPV vaccine: Recommended for all persons up to age 26, and catch‑up through age 45 when appropriate.
• Hepatitis B vaccine: Three‑dose series; 95 % protective.
• Hepatitis A vaccine: For high‑risk groups (e.g., travelers, men who have sex with men).

Pre‑Exposure Prophylaxis (PrEP)

Daily oral tenofovir/emtricitabine (Truvada®) reduces HIV acquisition by >90 % in high‑risk individuals. Discuss with your provider if you have ongoing exposure risk.

Regular Screening & Prompt Treatment

Early detection and treatment stop the chain of transmission. Encourage friends and partners to get tested.

Education & Communication

• Talk openly with partners about sexual histories and STI testing.
• Use reputable resources (CDC, WHO) for up‑to‑date information.

Complications

If left untreated, STIs can cause serious short‑ and long‑term health problems.

• Pelvic inflammatory disease (PID): Ascending infection from chlamydia or gonorrhea leading to infertility, ectopic pregnancy, chronic pelvic pain.
• Neonatal infections: Conjunctivitis, pneumonia, or sepsis in newborns born to mothers with chlamydia, gonorrhea, or syphilis.
• Increased HIV susceptibility: Ulcerative STIs (herpes, syphilis) disrupt mucosal barriers, raising HIV transmission risk.
• Cancer: High‑risk HPV types cause cervical, anal, oropharyngeal, and penile cancers.
• Neurologic complications: Neurosyphilis, herpes encephalitis, or HIV-associated neurocognitive disorder.
• Cardiovascular disease: Late syphilis can lead to aortitis or aneurysm.
• Chronic liver disease: Hepatitis B or C can progress to cirrhosis, hepatocellular carcinoma.

When to Seek Emergency Care

---

Sources: Centers for Disease Control and Prevention (CDC) 2024 STI Treatment Guidelines; World Health Organization (WHO) Global STI Report 2023; Mayo Clinic; Cleveland Clinic; National Institutes of Health (NIH) publications; peer‑reviewed journals “The Lancet Infectious Diseases” and “Clinical Infectious Diseases”.

```